NCT05733598
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05733598
Title Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Replimune Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Beverly Hills Cancer Center RECRUITING Beverly Hills California 90211 United States Details
UC San Diego Moores Cancer Center RECRUITING La Jolla California 92037 United States Details
Sylvester Comprehensive Cancer Center (University of Miami Hospital and Clinics) RECRUITING Miami Florida 33136 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
University of Louisville RECRUITING Louisville Kentucky 40202 United States Details
University of Maryland Medical Center RECRUITING Baltimore Maryland 21201 United States Details
Roswell Park Comprehensive Cancer Center RECRUITING Buffalo New York 14236 United States Details
Montefiore Medical CenterMontefiore Medical Park RECRUITING The Bronx New York 10461 United States Details
University of Pennsylvania, Abramson Cancer Center RECRUITING Philadelphia Pennsylvania 19104 United States Details
UPMC Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
The West Clinic RECRUITING Germantown Tennessee 38138 United States Details
University of Tennessee Medical Center RECRUITING Knoxville Tennessee 37920 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field